Hospitalizations for Varicella in Children
PDF (Spanish)

Keywords

Chickenpox
Chickenpox vaccine.
Chickenpox / complications
Child
Hospitalization

How to Cite

1.
Pérez Solís D, Pardo de la Vega R, Prieto Espuñes S, Callejo Ortea A. Hospitalizations for Varicella in Children. Bol Pediatr. 2001;41(177):175-181. doi:10.63788/wpxtsr87

Abstract

Objective: To describe hospitalizations for varicella and its complications in our hospital and to compare them with published data.

Patients and methods: Retrospective study of hospital records of patients less than 14 years of age hospitalized for varicella or its complications from 1990 to 2000. Newborns were excluded. Descriptive statistical analysis was performed.

Results: We identified 65 children hospitalized for varicella and/or varicella complications, which represent 3.9% of varicella cases who visited the paediatric emergency unit. The mean age was 4.4 ± 2.7 years (72.3 % were 5 years old or younger). Most patients (58.5%) were previously healthy children. The median of the hospital stay was 5 days (range 1-42 days), and 5 children needed admission in paediatric intensive care unit. The most common complications were neurological (32.8 %) and skin/soft tissue infections (26.2%). We also found respiratory complications (14.8%) -specially pneumonia, gastrointestinal (8.2%), haematological (6.6%) and osteoarticular complications (4.9%). We detected invasive group A streptococcal disease in two patients with cellulitis. There were no cases of streptococcal toxic shock syndrome, necrotizing fasciitis, Reye syndrome nor deaths.

Conclusions: Although varicella is usually a benign illness, it may cause severe complications, whose distribution varies for socio-economic and geographic factors,, and it is responsible for high costs to health care system. Inclusion of varicella vaccine ?particularly effective for severe disease? in our immunization schedule should be considered.

PDF (Spanish)

References

Comité asesor de vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría 2001-2002. An Esp Pediatr 2001; 55: 30-38. https://doi.org/10.1016/S1695-4033(01)77622-9

Gil A, González A, Dal Re R, Ortega P, Domínguez V. Prevalen- ce of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish ado- lescents. J Infect 1998; 36: 53-56. https://doi.org/10.1016/S0163-4453(98)93126-7

Comité asesor de vacunas. Asociación Española de Pediatría. Manual de Vacunas en Pediatría. Segunda edición. Madrid: Lito- finter, S.L.; 2001.

Tarlow MJ, Walters S. Chickenpox in childhood. A review pre- pared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36 (Suppl. 1): 39-47. https://doi.org/10.1016/S0163-4453(98)80154-0

Bullowa JGM, Wishik SM. Complications of varicella: I. Their occu- rrence among 2534 patients. Am J Dis Child 1935; 49: 923-926. https://doi.org/10.1001/archpedi.1935.01970040091011

Centers for Disease Control and Prevention. Prevention of vari- cella: Recommendations of the Advisory Committee on Immuni- zation Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996; 45: 1-36.

Jackson MA, Burry VF, Olson LC. Complications of varicella requi- ring hospitalization in previously healthy children. Pediatr Infect Dis J 1992; 11: 441-445. https://doi.org/10.1097/00006454-199206000-00004

Jaeggi A, Zurbruegg RP, Aebi C. Complications of varicella in a defined central European population. Arch Dis Child 1998; 79: 472- 477. https://doi.org/10.1136/adc.79.6.472

Peterson CL, Mascola L, Chao SM, Lieberman JM, Arcinue EL, Blumberg DA et al. Children hospitalized for varicella: a prevac- cine review. J Pediatr 1996; 129: 529-536. https://doi.org/10.1016/S0022-3476(96)70117-8

Riaza Gómez M, de la Torre Espí M, Mencía Bartolomé S, Molina Cabañero JC, Tamariz-Martel Moreno A. Complicaciones de la varicela en niños. An Esp Pediatr 1999; 50: 259-262.

American Academy of Pediatrics. Committee on Infectious Dise- ases. Varicella vaccine update. Pediatrics 2000; 105: 136-141. https://doi.org/10.1542/peds.105.1.136

The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269: 390-391. https://doi.org/10.1001/jama.1993.03500030088038

Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993; 269: 384-389. https://doi.org/10.1001/jama.1993.03500030082037

Laupland KB, Davies HD, Low DE, Schwartz B, Green K, the Onta- rio Group A Streptococcal Study Group et al. Invasive group A streptococcal disease in children and association with varicella- zoster virus infection. Pediatrics 2000; 105: E60. https://doi.org/10.1542/peds.105.5.e60

Zerr DM, Alexander ER, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varice- lla. Pediatrics 1999; 103: 783-790. https://doi.org/10.1542/peds.103.4.783

Díez Domingo J. Epidemiology and cost analysis of varicella: a prospective study in primary care centers. 4th Meeting European Working Group on Varicella Vaccination. Madrid 2001.

Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Hol- mes SJ et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375-381. https://doi.org/10.1001/jama.1994.03510290057037

Beutels P, Clara R, Tormans G, Van Doorslaer E, Van Damme P. Costs and benefits of routine varicella vaccination in German chil- dren. J Infect Dis 1996; 174 (Suppl. 3): S335-S341. https://doi.org/10.1093/infdis/174.Supplement_3.S335

Coudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in healthy children: cost-benefit analysis of the situa- tion in France. Vaccine 1999; 17: 142-151. https://doi.org/10.1016/S0264-410X(98)00161-3

Díez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost benefit analysis of routine varicella vaccination in Spain. Vaccine 1999; 17: 1306-1311. https://doi.org/10.1016/S0264-410X(98)00394-6

Centers for Disease Control and Prevention. Varicella-related deaths among adults: United States, 1997. MMWR Morb Mortal Wkly Rep 1997; 46: 409-412.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2001 Boletín de Pediatría